Racial Disparities: 2023 Diabetes Diagnosis in Cancer Patients Gaole Song, DrPH - Synopsis below extracted from the video transcript.
CAR T-cell: Advances in Adoptive Therapies for Targeting Heterogeneity in mCRPC Lupita Lopez - Synopsis below extracted from the video transcript.
Lung Cancer EGFR: What Are The Latest Advanced Treatments in 2023? Insights from Ravi Salgia MD - Synopsis below extracted from the video transcript.
How effective is mosunetuzumab in treating lymphoma? - [Slides] Elizabeth Budde, MD 2023 reviews new therapies - Synopsis below extracted from the video transcript.
Lung Cancer EGFR: What Are The Latest Advanced Treatments in 2023? Insights from Ravi Salgia MD - Synopsis below extracted from the video transcript.
Poster discussed by Anna Odell, City of Hope - Friends of Cancer Research - Dr. Monty Pal served as a guide and advisory mentor.
In this poster, Anna Odell discusses the studies for treating RCC. "Evaluation of eligibility criteria in contemporary renal cell cancer trials based on ASCO-FCR recommendations.". She emphasizes the need of carefully choosing patients for clinical trials based on the specific molecular and genetic qualities they possess, and she describes the many types of RCC, including papillary and clear cell RCC.